GraphPad

For 25 years, GraphPad has been the leading provider of software developed exclusively for the international scientific community. GraphPad Prism, the company’s flagship product, is the preferred analysis and graphing solution purpose-built for scientific research. Powerful, yet intuitive and helpful, Prism helps scientists discover and share the story in their data. Prism has been trusted by more than 750,000 of the world’s leading scientists, from students to Nobel Prize winners, in institutions and organizations including Stanford, Yale, Harvard, City of Hope, Center for Disease Control and Prevention (CDC), NASA, Merck, Sanofi, and more. Founded by Dr. Harvey Motulsky—a renowned pharmacologist, biostatistician, and author of the best selling Intuitive Biostatistics: A Nonmathematical Guide to Statistical Thinking—the company received an investment from Insight Venture Partners in 2017. Insight Venture Partners is a leading venture capital and private equity firm investing in high-growth companies that are driving transformative change in their industries.